Gene therapy startup Lexeo files to go public in shrinking window for IPOs before Thanksgiving

The gene therapy startup Lexeo Therapeutics filed paperwork to go public Friday afternoon, as the pre-Thanksgiving IPO window shrinks and a government shutdown looms.

The New York-based biotech would join about a dozen other drug developers in going public this year, aiming to trade on the Nasdaq under the ticker $LXEO….
Click here to view original post